1. Home
  2. EXAS vs OLED Comparison

EXAS vs OLED Comparison

Compare EXAS & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • OLED
  • Stock Information
  • Founded
  • EXAS 1995
  • OLED 1985
  • Country
  • EXAS United States
  • OLED United States
  • Employees
  • EXAS N/A
  • OLED N/A
  • Industry
  • EXAS Medical Specialities
  • OLED Semiconductors
  • Sector
  • EXAS Health Care
  • OLED Technology
  • Exchange
  • EXAS Nasdaq
  • OLED Nasdaq
  • Market Cap
  • EXAS 11.6B
  • OLED 9.8B
  • IPO Year
  • EXAS N/A
  • OLED 1992
  • Fundamental
  • Price
  • EXAS $59.25
  • OLED $159.08
  • Analyst Decision
  • EXAS Strong Buy
  • OLED Strong Buy
  • Analyst Count
  • EXAS 16
  • OLED 8
  • Target Price
  • EXAS $72.80
  • OLED $215.63
  • AVG Volume (30 Days)
  • EXAS 2.2M
  • OLED 652.1K
  • Earning Date
  • EXAS 11-05-2024
  • OLED 10-30-2024
  • Dividend Yield
  • EXAS N/A
  • OLED 1.03%
  • EPS Growth
  • EXAS N/A
  • OLED 15.56
  • EPS
  • EXAS N/A
  • OLED 4.98
  • Revenue
  • EXAS $2,692,328,000.00
  • OLED $643,711,000.00
  • Revenue This Year
  • EXAS $11.81
  • OLED $12.66
  • Revenue Next Year
  • EXAS $11.41
  • OLED $11.79
  • P/E Ratio
  • EXAS N/A
  • OLED $31.22
  • Revenue Growth
  • EXAS 11.91
  • OLED 9.63
  • 52 Week Low
  • EXAS $40.62
  • OLED $148.75
  • 52 Week High
  • EXAS $79.62
  • OLED $237.00
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 48.86
  • OLED 36.82
  • Support Level
  • EXAS $61.28
  • OLED $154.60
  • Resistance Level
  • EXAS $62.15
  • OLED $165.00
  • Average True Range (ATR)
  • EXAS 2.02
  • OLED 4.11
  • MACD
  • EXAS 0.15
  • OLED 0.84
  • Stochastic Oscillator
  • EXAS 3.39
  • OLED 18.80

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: